CD8A and neoplasm: This resulted in the increased activity of signaling pathways and transcription factors that enhance TMEM cell development, such as AMPK which negatively regulated mTOR and Foxo1, and resulted in enhanced anti-tumor activity of CD8+ T cells (106).